Does proton pump inhibitor (PPI) therapy increase the risk of fractures?
Metadata[+] Show full item record
In the absence of other risk factors, PPI use is not associated with an increased risk of hip fractures, osteoporosis, or loss of bone mineral density (BMD) at the hip or spine. (SOR: B, based on case-controlled and cohort studies.)
Evidence Based Practice 14(6): 10-11.